|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.40 TWD | -2.56% |
|
-7.30% | +33.33% |
| 1 day | -2.56% | ||
| 1 week | -7.30% | ||
| Current month | +5.19% | ||
| 1 month | +1.25% | ||
| 3 months | -13.25% | ||
| 6 months | +36.71% | ||
| Current year | +33.33% |
| 1 week | 31.55 | 34.4 | |
| 1 month | 29.95 | 37.35 | |
| Current year | 20 | 45.95 | |
| 1 year | 16.5 | 45.95 | |
| 3 years | 13.85 | 45.95 | |
| 5 years | 13.85 | 46.3 | |
| 10 years | 13.85 | 46.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Chun Wang
CEO | Chief Executive Officer | - | 21/07/2008 |
Shu Min Ni
DFI | Director of Finance/CFO | - | 01/10/2012 |
Jiun-Wen Wu
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Chun Wang
CHM | Chairman | - | 21/07/2008 |
Chiung Hua Juan
BRD | Director/Board Member | 57 | 09/11/2022 |
Ming Wen Li
BRD | Director/Board Member | - | 29/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.56% | -7.30% | +86.21% | -4.14% | 45.44M | ||
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | ||
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | ||
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | ||
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | ||
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | ||
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | ||
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | ||
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | ||
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | ||
| Average | +0.18% | +1.04% | +32.20% | +46.71% | 364.31B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.15% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | NT$32.40 | -2.56% | 135,671 |
| 23/07/26 | NT$33.25 | -2.49% | 177,450 |
| 22/07/26 | NT$34.10 | +3.96% | 346,697 |
| 21/07/26 | NT$32.80 | -0.30% | 199,233 |
| 20/07/26 | NT$32.90 | -5.87% | 351,292 |
- Stock Market
- Stocks
- 6917 Stock
Select your edition
All financial news and data tailored to specific country editions
















